Tema Heart & Health ETF (NASDAQ:HRTS – Get Free Report)’s stock price dropped 3.3% during trading on Thursday. The stock traded as low as $38.47 and last traded at $38.5110. Approximately 6,008 shares traded hands during trading, an increase of 18% from the average daily volume of 5,088 shares. The stock had previously closed at $39.84.
Tema Heart & Health ETF Stock Performance
The firm has a market cap of $57.00 million, a price-to-earnings ratio of 29.47 and a beta of 0.60. The business has a fifty day moving average of $36.97 and a two-hundred day moving average of $35.63.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently made changes to their positions in the company. Rothschild Capital Partners LLC purchased a new position in Tema Heart & Health ETF during the 2nd quarter valued at about $651,000. Members Advisory Group LLC acquired a new stake in shares of Tema Heart & Health ETF in the second quarter valued at approximately $398,000. Anson Capital Inc. acquired a new stake in shares of Tema Heart & Health ETF in the second quarter valued at approximately $297,000. XML Financial LLC purchased a new position in shares of Tema Heart & Health ETF during the 2nd quarter worth approximately $223,000. Finally, Royal Bank of Canada raised its position in shares of Tema Heart & Health ETF by 8.8% during the 1st quarter. Royal Bank of Canada now owns 21,083 shares of the company’s stock worth $710,000 after purchasing an additional 1,703 shares during the last quarter.
About Tema Heart & Health ETF
The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive. HRTS was launched on Nov 20, 2023 and is issued by Tema.
Further Reading
- Five stocks we like better than Tema Heart & Health ETF
- Google’s Credit Backstop May Be TeraWulf’s Biggest Advantage
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
- Qualcomm Beat Earnings, But Its Fastest-Growing Businesses Have a Catch
- Oil, Uranium, or Renewables? 3 Energy Plays for a Changing Market
Receive News & Ratings for Tema Heart & Health ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tema Heart & Health ETF and related companies with MarketBeat.com's FREE daily email newsletter.
